drugset / Trial / NCT01119508
Ipilimumab + Temozolomide in Metastatic Melanoma
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if combining ipilimumab and temozolomide can help to control metastatic melanoma. The safety of this drug combination will be studied. Researchers would also like to study how this therapy affects the levels of certain chemicals in the blood that are related to your immune system.
Timeline
- Start
- 2010-05
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipilimumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Temozolomide | Small molecule | 200 mg/m2 | Oral |